Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
HYPR
STRONG SELLHyperfine, Inc. · Healthcare · United States · $95M · Avg Vol: $1M/d
COMPANY DESCRIPTION
Hyperfine, Inc. is a medical device company that develops and commercializes the Swoop® Portable MR Imaging System, the world's first and only FDA-cleared portable magnetic resonance imaging solution. The company's innovative technology significantly reduces the cost and infrastructure requirements of traditional MRI, enabling point-of-care brain imaging in diverse clinical and non-clinical settings. It positions itself as a disruptive force in diagnostic imaging, aiming to expand MRI accessibility globally.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.8M | 11.0M | 12.9M | 13.6M | 25.8% | 15.3M | 20.2M | 26.3M | 39.2% |
| EPS | -1.04 | -0.62 | -0.56 | -0.43 | — | -0.42 | -0.34 | -0.34 | — |
| Shares | 70.7M | 71.9M | 73.1M | 97.2M | +37.6% | 84.2M | — | — | — |
| Debt | 0 | 0.2M | 0.3M | 0.2M | 15.8% | — | — | — | — |
| Equity | 123.7M | 84.4M | 49.0M | 41.0M | -30.8% | — | — | — | — |
| Op CF | -72.3M | -41.8M | -38.8M | -27.9M | — | -27.7M | — | — | — |
| Inv CF | -0.6M | -0.8M | -0.4M | -1.2M | — | — | — | — | — |
| Fin CF | 7.0K | 0.2M | 1.0M | 27.5M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of HYPR are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| HYPR | Hyperfine, Inc.(you) | $95M | 13 | STRONG SELL |
| CVRX | CVRx, Inc. | $126M | 12 | STRONG SELL |
| OM | Outset Medical, Inc. | $75M | 15 | STRONG SELL |
| STIM | Neuronetics, Inc. | $120M | 15 | STRONG SELL |
| LNSR | LENSAR, Inc. | $69M | 11 | STRONG SELL |
| RPID | Rapid Micro Biosystems, Inc. | $99M | 4 | STRONG SELL |
| AVH.AX | AVITA Medical, Inc. | $115M | 19 | STRONG SELL |
| SERA | Sera Prognostics, Inc. | $80M | 5 | STRONG SELL |
| OWLT | Owlet, Inc. | $153M | 11 | STRONG SELL |
| QSI | Quantum-Si incorporated | $168M | 11 | STRONG SELL |
Peer medians: ROE -25.5% · P/E 27.7x · Gross margin 50.5%